The role of post-operative cetuximab-based bioradiotherapy in high risk head and neck carcinomas.
Phase 2
- Conditions
- Head and neck squamous cell carcinomas
- Registration Number
- JPRN-UMIN000017634
- Lead Sponsor
- Department of Otolaryngology- Head and Neck Surgery, Hokkaido University Graduate school of Medicine.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
The cases with a history of Interstitial pneumonia. The cases with a history of irradiation on head and neck region. The cases that researchers regard as inadequate.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Completion rate of this treatment Probability of adverse effect
- Secondary Outcome Measures
Name Time Method Overall survival rate Disease free survival rate Loco-regional control rate Probability of distant metastasis